ARCHIVES

FDA says new tools needed to speed therapeutics development.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

January 26, 2007

Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin

July 27, 2012

Broder On FDA: Don’t Blame Them For Doing Their Jobs (They Have To Work At Parklawn)

September 27, 1991

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011